Fig. 1From: Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsisPatient enrollment in DrotAA and nonDrotAA groups. Superscript notes: 1Based on GoldenGate genotyping for AIM panel SNPs and research SNPs. 2Each matched set required 1 DrotAA-treated patient and 1–3 nonDrotAA-treated patientsBack to article page